PREPlab

Stop PREP to stop neurodegeneration?

We are studying the role of prolyl oligopeptidase (PREP, formerly known as POP) on disease progression and neuronal toxicity in neurodegenerative disorders with protein aggregation. These disorders involve several serious diseases such as Alzheimer’s and Parkinson’s diseases, and several more rare neurodegenerative conditions. Based on PREP inhibitors, we are developing novel and disease-modifying drug therapies to stop the neuronal death in Alzheimer's and Parkinson's diseases.
Find more about PREP research

News

Recent news from PREP lab
@PREPresearch

Great event! Mark your calendars! #finpharmanet #dpdr @helsinkiuni twitter.com/finpharmanet/s…

Beautiful weather invited #PREPlab outside to have a small #piknik to celebrate Midsummer. Holding these kinds of e… twitter.com/i/web/status/1…

Very interesting news from Barcelona! #accuretherapeutics with long-term #prep researcher @teresa_tarrago is taking… twitter.com/i/web/status/1…

Long traditions of pre-clinical research in neurodegen disorders @helsinkiuni (P. Männistö, M. Saarma, R. Tuominen)… twitter.com/i/web/status/1…